1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma
    Meeting Abstract

    Benjamin, R.; Condomines, M.; Gunset, G.; Sadelain, M.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • A pilot study of single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer scheduled for mastectomy
    Meeting Abstract

    Diab, A.; McArthur, H. L.; Solomon, S.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J.; Gucalp, A.; Yuan, J.; Patil, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Bevacizumab (B) in the adjuvant treatment of breast cancer - First toxicity results from Eastern Cooperative Oncology Group trial E5103
    Meeting Abstract

    Miller, K. D.; O'Neill, A.; Dang, C.; Northfelt, D.; Gradishar, W.; Sledge, G. W.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib in combination with weekly paclitaxel for patients with metastatic breast carcinoma
    Meeting Abstract

    Morris, P. G.; Lake, D.; McArthur, H. L.; Gilewski, T.; Dang, C.; Chaim, J.; Patl, S.; Lim, K.; Norton, L.; Hudis, C. A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Tivozanib in combination with paclitaxel vs placebo with paclitaxel in patients with locally advanced or metastatic triple-negative breast cancer
    Meeting Abstract

    Mayer, E. L.; Miller, K.; O'Shaughnessy, J.; Dickler, M.; Vogel, C.; Leyland-Jones, B.; Steelman, L.; Robinson, M.; Kuriyama, N.; Agarwal, S.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Novel mutations in lobular carcinoma in situ (LCIS) as uncovered by targeted parallel sequencing
    Meeting Abstract

    De Brot, M.; Andrade, V. P.; Morrogh, M.; Berger, M. F.; Won, H. H.; Koslow Mutner, S.; Qin, L. X.; Giri, D. D.; Olvera, N.; Sakr, R. A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Reactivation of oncogenic signaling through mTOR inhibitors-induced feedback adaptations
    Meeting Abstract

    Rodrik-Outmezguine, V.; Chandarlapaty, S.; Poulikakos, P.; Scaltriti, M.; Baselga, J.; Rosen, N.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save